Sign In/ Sign Up
FDA Approves Intrarosa (prasterone) for Postmenopausal Women Experiencing Dyspareunia
Nov 21, 2016
The U.S. Food and Drug Administration approved Intrarosa (prasterone) to treat women experiencing moderate to severe pain during sexual intercourse (dyspareunia), a symptom of vulvar and vaginal atrophy (VVA), due to menopause. Intrarosa is the first FDA approved product containing the active ingredient prasterone, which is also known as dehydroepiandrosterone (DHEA)...